FGF23 and X-linked hypophosphatemia: An English-language search of PubMed, MEDLINE, and clinicaltrials.gov was performed using the terms burosumab, KRN23, X-linked hypophosphatemia, and FGF23 from January 2013 to February 2020 in March 2020.